Arcadia Biosciences, Inc.
RKDA- Exchange
- Nasdaq
- Industry
- Crude Petroleum & Natural Gas
- SEC CIK
- 0001469443
No open-market purchases or sales by Arcadia Biosciences, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $146.5K in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Arcadia Biosciences, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 14 | 11 | −3 |
| Shares | 81.0K | 28.7K | −52.3K (−64.5%) |
| Value | $178.3K | $90.4K | −$87.9K (−49.3%) |
New holders (2)
Institutions that held Arcadia Biosciences, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Advisor Group Holdings, Inc. | 88 | $276 | 0.00% |
| Bank of America Corp | 11 | $35 | 0.00% |
Sold out (5)
Institutions that held Arcadia Biosciences, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Sabby Management, LLC | 40,300 | $89.1K |
| Renaissance Technologies LLC | 10,453 | $23.0K |
| Wells Fargo & Company | 9 | $20 |
| UBS Group AG | 2 | $4 |
| VitalStone Financial, LLC | 1 | $0 |